Press release archive
| 23 February 2010 | 3i divests Nordic healthcare group Ambea for EUR 850 million3i, an international leader in private equity, and funds managed by 3i, have agreed the sale of their stake in Ambea, a leading private provider of healthcare and care services across the Nordic region... |
| 22 June 2011 | 3i sells KemFine to CABB3i, an international investor focused on private equity, infrastructure and debt management, and funds managed by 3i, have agreed to sell KemFine, a leading tier-one supplier to the fine chemicals market, to CABB, a German speciality chemicals company. |
| 22 June 2011 | 3i myy KemFinen CABB:lleKansainvälinen pääomasijoittaja 3i ja sen hallinnoimat rahastot ovat tehneet sopimuksen johtavan hienokemikaalien valmistajan KemFinen myymisestä CABB:lle, joka on saksalainen erikoiskemikaaliyhtiö. |
| 22 June 2011 | 3i säljer KemFine till CABB3i, en internationell investerare i private equity, infrastruktur och debt management, och fonder förvaltade av 3i har enats att sälja kemiföretaget KemFine till CABB, ett tyskt specialkemiföretag |
| 14 June 2011 | 3i säljer sina aktier i Ålö till Altor |
| 10 December 2010 | 3i agrees to buy OneMed from CapManAgreement to acquire OneMed, the leading northern European distributor of medical supplies to the healthcare services industry, from Nordic private equity firm CapMan. |
| 10 December 2010 | 3i ostaa OneMedin CapManiltaKansainvälinen pääomasijoittaja 3i ja sen hallinnoimat rahastot ovat solmineet sopimuksen OneMed-yhtiön ostosta pohjoismaiselta pääomasijoitusyhtiöltä CapManilta. |
| 23 February 2010 | 3i divests Nordic healthcare group Ambea for EUR 850 millionSale of stake in Ambea, a leading private provider of healthcare and care services across the Nordic region, to Triton for approximately € 850 million on a cash and debt free basis |
| 10 December 2010 | 3i förvärvar OneMed av CapMan3i och fonder, har undertecknat en överenskommelse att köpa OneMed, den ledande nordeuropeiska distributören av medicintekniska förbrukningsartiklar... |
| 25 October 2010 | 3i säljer sina aktier i Balco till Segulah IV3i har sålt sina aktier i Balco, en av Nordens ledande utvecklare och leverantörer av balkonger och inglasningssystem för dessa |
| 23 February 2010 | 3i avyttrar den nordiska vårdkoncernen Ambea för € 850 miljoner3i med fonder har tecknat avtal om att avyttra sitt innehav i Ambea, som är en ledande nordisk vård- och omsorgskoncern till Triton. Köpeskillingen uppgår till cirka € 850 miljoner i skuldfritt bolagsvärde. |
| 23 February 2010 | 3i myy terveydenhuoltokonserni Ambean 850 miljoonalla eurollaPääomasijoittaja 3i ja sen hallinnoimat rahastot myyvät enemmistöosuutensa Ambea-konsernista Tritonille. Ambea on johtava terveydenhuollon ja hoivapalveluiden toimittaja Pohjoismaissa. Kaupan arvo on noin 850 miljoonaa euroa. |
| 18 December 2009 | 3i myy osuutensa DNA:staPääomasijoittaja 3i myy 13 prosentin osuutensa teleoperaattori DNA Oy:stä Lännen Teletieto Oy:lle... |
| 02 February 2009 | 3i avyttrar sin andel i DIAB |
| 02 February 2009 | 3i divests stake in DIAB3i to divest stake in core materials manufacturer DIAB Group AB to private equity company Ratos |
| 19 November 2008 | 3i divests stake in digital TV operator Boxer3i has agreed to divest its 30 per cent stake in Nordic terrestrial digital pay television operator Boxer TV-Access AB to majority shareholder Teracom, the Swedish government-owned media operator, for an undisclosed sum. |
| 22 July 2008 | Soya Concept indgår partnerskab med kapitalfonden 3iSom led i et planlagt generationsskifte har Soya Concept indgået enpartnerskabsaftale med 3i’s Growth Capital, som specialiserer sig iminoritetsinvesteringer i privatejede virksomheder. |
| 01 June 2008 | Ny chef i Scandlines GmbHMichael Hassing er pr. 1. juni tiltrådt som koncernchef i Scandlines |
| 06 February 2008 | 3i indgår aftale om buyout af Alpharmas Active Pharmaceutical Ingredients-divisionKapitalfonden og ventureselskabet 3i har indgået en aftale om at medvirke til et buyout i Active Pharmaceutical Ingredients for 395 millioner dollars (knapt 2 mia. kroner). |
| 06 February 2008 | 3i förvärvar Alpharma Active Pharmaceutical Ingredients för 2,5 miljarder kronor3i Group plc, har tecknat avtal om att förvärva norska Alpharma Active Pharmaceutical Ingredients, en division inom Alpharma Inc. som är noterat på New York Stock Exchange (NYSE: ALO). |
| 22 November 2007 | 3i and Profita to sell Empower3i, a leading European private equity and venture capital firm, and Profita Fund II Ky, managed by Profita Management, a Finnish private equity company, have agreed to sell their shareholding in Empower |
| 15 November 2007 | 3i investerar i underklädesföretaget Agent Provocateur3i, Europe’s leading mid-market private equity company, and funds managed by 3i have signed an agreement to acquire Agent Provocateur, the luxury brand lingerie retailer. |
| 01 November 2007 | 3i sells Coor Service Management in a €540m dealPress Release 1 November 2007 3i sells Coor Service Management in a €540m deal3i, Europe’s leading private equity and venture capital company, has agreed to sell its stake in Coor Service Management Group AB, the Nordic region’s leading service |
| 29 June 2007 | PH-Lampen solgt til ItalienLouis Poulsen Lightning med de berømte PH-lamper er solgt til den italienske lampedesigner Targetti |
| 28 June 2007 | Targetti Sankey S.P.A. acquires 92.5% of Louis Poulsen A/STARGETTI SANKEY S.P.A.: Has reached an agreement to acquire 92.5% of the Danish company Louis Poulsen Lighting A/S (“Louis Poulsen”). |
| 19 June 2007 | 3i Invests in Inspecta3i, Europe’s leading mid-market private equity and venture capital company, and funds managed by 3i have signed an agreement to back the buyout of Inspecta. |
